Network-guided discovery of Zeqi Decoction as a PPARγ-targeted therapy for pulmonary fibrosis

This publication has 64 references indexed in Scilit:

• Genome-wide pan-GPCR cell libraries accelerate drug discovery
  Acta Pharmaceutica Sinica B, 2024
• Lipid metabolism in idiopathic pulmonary fibrosis: From pathogenesis to therapy
  Journal of Molecular Medicine, 2023
• Asiaticoside hampers epithelial–mesenchymal transition by promoting PPARG expression and suppressing P2RX7‐mediated TGF‐β/Smad signaling in triple‐negative breast cancer
  Phytotherapy Research, 2022
• Naringenin inhibits autophagy and epithelial‐mesenchymal transition of human lens epithelial cells by regulating the Smad2/3 pathway
  Drug Development Research, 2021
• Enhanced GROMACS: toward a better numerical simulation framework
  Journal of Molecular Modeling, 2019
• Naringenin Attenuates H2O2-Induced Mitochondrial Dysfunction by an Nrf2-Dependent Mechanism in SH-SY5Y Cells
  Neurochemical Research, 2017
• PPAR ligand association with prostaglandin F2α and E2 synthesis in the pig corpus luteum—An in vitro study
  Animal Reproduction Science, 2016
• Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivation
  Biochemical Pharmacology, 2016
• Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells
  Biochemical and Biophysical Research Communications, 2015
• Troglitazone-activated PPARγ inhibits LPS-induced lung alveolar type II epithelial cells injuries via TNF-α
  Molecular Biology Reports, 2010